Daihong Liu
Clinical trials sponsored by Daihong Liu, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo aims to boost CAR-T cell staying power in lymphoma Results expected May 2027 (estimated)
- New cell therapy targets EBV-Linked cancers in early trial Results expected Jun 2027 (estimated)
- New hope for stem cell transplant patients: combo therapy targets severe GVHD Results expected Jun 2027 (estimated)
- New immune cell therapy takes on virus after transplant Results expected Jun 2027 (estimated)
- Engineered immune cells target Hard-to-Treat myeloma with kidney issues Results expected Jul 2027 (estimated)